Sources | Names Used |
---|---|
GDSC1000 | Tivozanib |
CTRPv2 | tivozanib |
PharmacoGx | tivozanib |
Database | Identifier |
---|---|
Smiles: | CC1=CC(=NO1)NC(=O)NC2=C(C=C(C=C2)OC3=C4C=C(C(=CC4=NC=C3)OC)OC)Cl |
Inchikey: | SPMVMDHWKHCIDT-UHFFFAOYSA-N |
Pubchem: | 9911830 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | HBA1 | CTRPv2 | pan-cancer | AAC | 0.19 | 4e-08 |
mRNA | STAT5A | CTRPv2 | pan-cancer | AAC | 0.22 | 5e-08 |
mRNA | SPN | CTRPv2 | pan-cancer | AAC | 0.27 | 5e-08 |
mRNA | ERAS | GDSC1000 | pan-cancer | AAC | 0.18 | 5e-08 |
mRNA | HBA2 | CTRPv2 | pan-cancer | AAC | 0.19 | 5e-08 |
mRNA | RPL7A | CTRPv2 | pan-cancer | AAC | 0.21 | 6e-08 |
mRNA | HBM | CTRPv2 | pan-cancer | AAC | 0.19 | 6e-08 |
mRNA | PABPC1 | CTRPv2 | pan-cancer | AAC | 0.21 | 6e-08 |
mRNA | ALAS2 | CTRPv2 | pan-cancer | AAC | 0.19 | 6e-08 |
mRNA | TARBP1 | CTRPv2 | pan-cancer | AAC | 0.21 | 6e-08 |